article thumbnail

5 strategies for biotech startups to outlast a market downturn

TechCrunch

James Coates is the Health and Human Performance principal at Decisive Point , a venture capital and advisory firm that invests in and supports startups with emerging defense technologies. This is especially true for biotech startups, where investment needs are higher and success timelines can be much longer.

Biotech 231
article thumbnail

6 investors discuss why AI is more than just a buzzword in biotech

TechCrunch

That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.

Biotech 242
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. The life sciences industry is known for its unique challenges in recruiting and hiring.

Biotech 178
article thumbnail

In an increasingly hot biotech market, protecting IP is key

TechCrunch

2021 should be a banner year for biotech startups that make smart choices early. After a record year for biotech investment in 2020 — during which the industry saw $28.5 Since 1996 , 14,000 startups have licensed technology out of those universities, and 67% of licenses were taken by startups or small companies. Kevin O’Connor.

Biotech 240
article thumbnail

IPO Readiness: What Biotech Startups And Others Need To Know

Crunchbase News

Given this success, many biotech companies are looking to move on to the next phase of their organizational growth — which may mean an initial public offering. As optimism grows, market conditions may stabilize in 2025 — particularly in the wake of the recent interest rate cuts — and more biotech companies may consider offerings.

Biotech 54
article thumbnail

The Week’s 10 Biggest Funding Rounds: Crusoe Energy, Insider And Biotech Raise Big

Crunchbase News

startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. The latest startup in the space to get a big chunk of cash is Beta Technologies, maker of electric vertical take-off and landing planes. billion valuation in the process.

Biotech 102
article thumbnail

5 ways biotech startups can mitigate risk to grow sustainably in the long run

TechCrunch

Omar Khalil is a partner at Santé Ventures , where he focuses primarily on biotechnology and medical technology companies. Capital is the fuel that advances scientific and technological innovation, and it means a life science startup can create products that benefit the world at large. Omar Khalil. Contributor. Share on Twitter.

Biotech 242